|
TJP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.491700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.368000E-02 |
| Normal-vs-Stage2 |
4.455800E-01 |
| Normal-vs-Stage3 |
6.115800E-02 |
| Normal-vs-Stage4 |
2.584600E-01 |
| Stage1-vs-Stage2 |
9.787200E-01 |
| Stage1-vs-Stage3 |
1.665680E-02 |
| Stage1-vs-Stage4 |
1.687760E-01 |
| Stage2-vs-Stage3 |
7.345800E-02 |
| Stage2-vs-Stage4 |
2.462800E-01 |
| Stage3-vs-Stage4 |
8.438800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.282400E-02 |
| Normal-vs-AfricanAmerican |
4.416600E-01 |
| Normal-vs-Asian |
5.8692999999943E-05 |
| Caucasian-vs-AfricanAmerican |
4.530600E-01 |
| Caucasian-vs-Asian |
2.004700E-03 |
| AfricanAmerican-vs-Asian |
4.541800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.771700E-02 |
| Normal-vs-Female |
6.446200E-02 |
| Male-vs-Female |
3.820800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.205400E-01 |
| Normal-vs-Extreme_Weight |
1.624190E-01 |
| Normal-vs-Obese |
2.074200E-01 |
| Normal-vs-Extreme_Obese |
9.530400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.420970E-01 |
| Normal_Weight-vs-Obese |
1.859170E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.534800E-01 |
| Extreme_Weight-vs-Obese |
9.258400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.656400E-01 |
| Obese-vs-Extreme_Obese |
5.573600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.583000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.256700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.090400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.760600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.758800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.492600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.527400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.973600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.250200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.039200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.030199999974E-06 |
| Normal-VS-Type2 PRCC |
3.957100E-03 |
| Normal-VS-KIRP CIMP |
7.329400E-01 |
| Normal-VS-Unclassified PRCC |
7.112600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.39459999104474E-10 |
| Type1 PRCC-VS-KIRP CIMP |
8.938000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.170000E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.821000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.116780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.047400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.550640E-01 |
| Normal-vs-N1 |
1.545830E-01 |
| Normal-vs-N2 |
5.799600E-01 |
| N0-vs-N1 |
8.515000E-01 |
| N0-vs-N2 |
8.277800E-01 |
| N1-vs-N2 |
8.845400E-01 |
|
|
